THE STUDY OF CELLULAR FACTORS OF IMMUNITY IN PATIENTS WITH NON-HODGKIN'S LYMPHOMAS
Abstract
The purpose of this study was to study the basic cellular indicators of immunity in patients with non-Hodgkin's lymphomas to substantiate the immunopathogenetic features of the course of the disease. It turned out to be important that patients were divided into 2 groups with virus carrier and without virus carrier.
An analysis of the results allowed us to identify pronounced changes in the cellular immunity that manifested themselves by suppressing the expression of CD3 +, CD3 + CD4 +, IRI, against this background, an increase in the expression of CD3 + CD8 +, CD16 + and CD20 + B cells, as well as increased expression of activation molecular markers of CD38 + lymphocytes, CD95 +. Deep T-cell immunodeficiency was detected against the background of pathological activation of lymphocytes, which is clinically often reflected by frequent relapses, an unfavorable course of the disease, and treatment results.
References
Ansell S.M., Horwitz S.M., Engert A. et al. Phase L/II study of an anti-CD30-monoclonal antibody (MDX-060) in Hodgkin's lymphoma and anaplastic large-cell lymphoma // J Clin Oncol. 2007. - Vol. 25, N 19. - P. 2764-2769.
Atamer T., Artim-Esen- B., Yavus S. et al. Massive post-obstructive disuresis in a patient with Burkitt's lymphoma // Nephrol. Dial. Transplant. 2005. -N 6. - P. 28.
Gasses A., Kirby M., Weitzman S. Hepatosplenic gammadelta T-cell lymphoma in a 10-year-old boy successfully treated with hematopoetic sterm cell transplantation // Am. J. Hematol. 2004. - Vol. 12, N 2. - P. 113-114.
Hutchison R., Berard C., Shuster J. et al. B-cell lineage confers a favorable outcome among children and adolescents with large-cell lymphoma: a Pediatric Oncology Group study // J. Clin. Oncol. 1995. - Vol. 13. - P. 2023-2032.
Jakson R. et al. Extranodal follicular lymphoma: a clinicopathological and genetic analysis of 15 cases arising at non-cutaneous extranodal sites // Histopathology. 2004. — Vol. 44, N 3. - P. 268-276.
Kavan P., Kabickova E., Gajdos P. et al. Treatment of pediatric B-cell non-Hodgkin's lymphomas at the Motol Hospital in Prague, Czech Republic: results based on the NHL BFM 90 protocols // Pediatr. Hematol. Oncol. 1999. - Vol. 16, N 3. - P. 201-212.
Klein U., Klein G., Ehlin-Henriksson B. et al. Burkitt's lymphoma is a malignancy of mature B-cells expressing somatically mutated V region genes // Mol. Med. 1995. — N 1. — P. 495-506.
Kline J., Larson R. Nelarabine in the treatment of refractory T-cell malignant diseases // Expert. Opin. Pharmacother.-2006.-Vol. 7,N 13.-P. 1791-1799.
Lindeman N. et al. One patient, two lymphomas. Simultaneous primary gastric marginal zone lymphoma and primary duodenal follicular lymphoma // Arch. Pathol. Lab. Med. -2004. Vol. 128, N9.-P. 1035-1038.
Malani A.K., Gupta C., Weigand R.T. et al. Spinal Burkitt's lymphoma in adults // Clin. Lymphoma Myeloma. 2006. - Vol. 6, N 4. - P. 333-336.
Manzur A., Zaidi S. Hypopigmented mycosis fungoides in a 10-year-old boy // Dermatol. Online J. 2006. - Vol. 31, N6.-P.21.
Marte A., Sabatino M., Cautiero P. et al. Unexpected finding of laparoscopic appendectomy: appendix MALT lymphoma in children // Pediatr. Surg. Int. 2007. - Vol. 7. -P. 119-123.
Mawanda O.W. Aspects of epidemiological and clinical features of patients with central nervous system Burkitt's lymphoma in Kenia // East. Afr. Med. J. 2004. - Vol. 8. — P. 97103.
Mawanda O.W. Clinical characteristics of Burkitt's lymphoma seen in Kenyan patients // East. Afr. Med. J. 2004. - N 8. - P. 78-89.
Sharkey R., Karacay H., Johnson C. et al. Pretargeted versus directly targeted radioimmu-notherapy combined with anti-CD20 antybody consolidation therapy of Non-Hodgkin lymphoma//J.Nucl.Med. 2009. - Vol. 17.-P. 123-128.
Windsor R., Stiller C., Webb D. Peripheral T-cell lymphoma in childhood: population-based experience in the United Kingdom over 20 years // Pediatr. Blood Cancer. — 2007. -Vol. 11.-P. 87-91.
Views:
151
Downloads:
132
Copyright (c) 2019 The Authors
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.
